A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Clinical trial NCT05879718 · TERMINATED

Trial details

NCT number: NCT05879718
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic Lupus Erythematosus, Cutaneous

Start date: 2023-07-07
Primary completion: 2025-06-05
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.